Dog and guinea-pig testicular extract

animal tissue

provenance:animal tissue

first introduced:1889

regulatory status:withdrawn

context:Brown-Séquard used aqueous extract of guinea-pig and dog testes for his June 1889 self-injection experiment, reported to the Société de Biologie in Paris on 1 June 1889 and published in *The Lancet* (1889;2:105-107) later the same summer. He selected the source animals on the basis of availability and assumed biological similarity to the human testis; the same materials were used in the commercial preparations of 'Brown-Séquard's elixir' and related testicular-extract products sold by pharmacists from 1890 onward.

MECHANISM CLAIMED

Extract of freshly removed animal testes contains a 'vital substance' secreted by the testes that diminishes with age and that, when injected subcutaneously, restores physical and mental vigor in older men through exogenous supplementation of the lost endogenous factor.

MECHANISM ACTUAL

Aqueous extraction by maceration of fresh tissue in water or saline, followed by gauze filtration without concentration, yields a preparation with essentially no testosterone content. Modern reconstruction (Cussons et al, *Med J Aust* 2002) estimates the testosterone delivered per injection at roughly four orders of magnitude below any therapeutic dose. The 'vital substance' premise was directionally correct (testes do secrete an active substance later identified as testosterone) but the preparation method delivered none of it. Reported clinical effects are placebo response.

INTERVENTIONS USING IT

Brown-Séquard testicular extract (organotherapy)

NOTES

Dog and guinea-pig testicular extract was the active material in Brown-Séquard’s 1889 self-injection protocol and in the commercial testicular-extract preparations sold from 1890 onward across Europe and North America. The crude aqueous extraction method delivered no biologically meaningful dose of testosterone; the substance is the canonical example of a rejuvenation ingredient whose proposed mechanism was directionally correct in concept but completely failed in preparation. The ingredient anticipates the broader pattern of biological-substance-transfer rejuvenation in which the donor material is biologically plausible-sounding but the actual delivery is therapeutically inert.